SCHEMBL6204762

SCHEMBL6204762

CC(Oc1ccccc1)=C(C(=O)O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.53
CYP1A2 P05177 1/20 0.46
MAPT P10636 4/20 0.44
TDP1 Q9NUW8 3/20 0.44
CES2 O00748 2/20 0.43
CES1 P23141 2/20 0.43
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
TSHR P16473 1/20 0.42
HSP90AA1 P07900 1/20 0.42
GAA P10253 1/20 0.42
PARP10 Q53GL7 1/20 0.42
NSD2 O96028 1/20 0.42
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206065 0.79 TSHR (0.47) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6204948 0.79 ELANE (0.51) ELANECYP1A2MAPTTDP1CES2
SCHEMBL1145279 0.79 ELANE (0.51) ELANECYP1A2MAPTTDP1CES2
SCHEMBL8975527 0.79 TSHR (0.56) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6065985 0.79 ELANE (0.47) ELANECYP1A2MAPTTDP1ALDH1A1
SCHEMBL6205997 0.78 ELANE (0.43) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6206652 0.78 ELANE (0.43) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6206053 0.78 ELANE (0.43) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6206639 0.78 ELANE (0.43) ELANECYP1A2MAPTTDP1CES2
SCHEMBL6204819 0.78 TDP1 (0.44) ELANECYP1A2MAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed